Sarah Whaley is program manager of the Bloomberg Overdose Prevention Initiative at Johns Hopkins Bloomberg School of Public Health. She's supported by Michael R. Bloomberg, founder of Bloomberg LP and Bloomberg Philanthropies. The numbers in 2021 are four times higher than they were in the late 90s when OxyContin hit the market. And that is because we're in this era where the main cause of overdose deaths are synthetic opioids like fentanyl.
Bloomberg Commodities Edge Anchor Alix Steel and Bloomberg News Senior US Oil Reporter Kevin Crowley break down the news that Exxon is buying Denbury for $4.9 billion in a deal that will provide the oil giant the largest network of carbon dioxide pipelines in the US. Sara Whaley, Research Associate for Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, explains the most effective use of opioid litigation funds. Bloomberg Businessweek Columnist Max Chafkin talks about his Businessweek Magazine story Would-Be Twitter Replacements Chase an Audience Ready to Log Off. And we Drive to the Close with Doug Ciocca, CEO at Kavar Capital.
Hosts: Carol Massar and Matt Miller. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.